Liver Tumor
Pediatric liver tumors are rare, with approximately 200 cases diagnosed each year in the United States. The most common types include hepatoblastoma (HB), which typically occurs in young children, as well as hepatocellular carcinoma (HCC) and fibrolamellar carcinoma (FLC), which are more often seen in older children, adolescents, and young adults.
While hepatoblastoma is often treatable, therapy can result in significant long-term health effects—including heart dysfunction, hearing loss, and the potential need for liver transplant—and outcomes remain poor for patients with metastatic or relapsed disease. In contrast, HCC and FLC are often diagnosed at more advanced stages, when treatment options are limited and outcomes remain poor. Survival also varies by age, with better outcomes in younger children compared to those diagnosed later.
Across all liver tumor types, there remains a need for more effective therapies that both reduce long-term toxicity and improve outcomes for patients with advanced cases.
